期刊文献+

Toll样受体4与动脉粥样硬化关系的研究进展 被引量:2

The relationship between toll-like receptor 4 and atherosclerosis
原文传递
导出
摘要 动脉粥样硬化是心脑血管疾病的病理基础。但目前关于动脉粥样硬化的发病机制还不是很清楚。普遍认为免疫应答,包括固有免疫和适应性免疫在动脉粥样硬化的发生发展中起了重要作用。Toll受体4(TLR4)是抗原相关分子模式(PAMP)受体,在识别微生物感染、激发先天性免疫反应中发挥了重要作用。近来发现炎症在动脉粥样硬化发展的各个阶段均发挥了重要作用,虽然目前确切的证据还缺乏,但是越来越多的调查发现,病原体感染引起的分子和细胞的改变表明炎症具有这种作用。 Atherosclerosis is the major cause of cardiovascular and cerebrovascular diseases. However, the precise pathogenesis of atherosclerosis has not been clarified now o It is widely accepted that,immune mechanisms,including inr, ate immunity and acquired immunity,play important roles in the process of atherosclerosis o Toll-like receptor 4 (TLR4) is a pathogen-associated molecular pattern receptor, which plays an important role in innate immune signaling in response to microbial infection. Recent researches have recognized the fundamental role of inflammation in mediating all stages of atherosclerosis. Although the definite proof of the role of infection corttributing to atherosclerosis is lacking, more and more researches have demonstrated that infectious agents evoke cellular and molecular changes.
出处 《国际免疫学杂志》 CAS 北大核心 2009年第1期74-78,共5页 International Journal of Immunology
关键词 动脉粥样硬化 炎症 感染 TOLL样受体4 先天免疫 Atherosclerosis Inflammation hffection Toll-like receptor 4 Innate immunity
  • 相关文献

参考文献20

  • 1Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999,340(2) :115-126.
  • 2Muzio M, Polentarutti N, Bosisio D, et al. Toll-like receptors : a growing family of immune receptors that are differentially expressed and regulated by different leukecytes. J leukoc Biol, 2000,67 ( 4 ) : 450- 456.
  • 3Akira S,Takeda K. Toll-like receptor signalling. Nat Rev Immunol, 2004,4(7 ) :499-511.
  • 4Hacker H, Redecke V, Blagoev B, et al. Specificity in Toll-like receptor signalling through distinct efector functions of TRAF3 and TRAF6. Nature,2006,439 (7073) : 2 04 -207.
  • 5Takeda K, Kaisho T,Akira S. Toil-like receptors. Annu Rev Immunol, 2003,21:335-376.
  • 6Kawai T,Akira S. TLR signaling. Cell Death Difer,2006,13 (5) : 816 -825.
  • 7Yoshioka M, Fukuishi N, Kubo Y, et al. Human cathelicidin CAPI 8/ LL-37 changes mast cell function toward innate immunity . Biol Pharm Bull,2008,31 (2) :212-216.
  • 8Dagvadorj J, Naiki Y, Tumurkhuu G, et al. Interleukin-10 inhibits tumor necrosis factor- production in lipopolysaccharide-stimulated RAW 264.7 ceils through reduced MyD88 expression. Innate Immunity,2008,14 (2) : 109-115.
  • 9Gioannini TL, Weiss JP. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res,2007,39 ( 1-3 ) :249-260.
  • 10Tsutsumi-lshii Y, Shimada K, Daida H, et al. Low potency of chlamydophila LPS to activate human mononuclear cells due to its reduced affinities for CD14 and LPS-binding protein. Int Immunol,2008,20 ( 2 ) : 199 -208.

同被引文献8

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部